Abstract “Financial toxicity” has now become a familiar term used in the discussion of cancer
drugs, and it is gaining traction in the literature given the high price of newer classes of …

The American Society of Clinical Oncology released its first guidance statement on the cost
of cancer care in August 2009, affirming that patient‐physician cost communication is a …

Importance Navigating health insurance and health care choices requires considerable
health insurance literacy. Although recommended preventive services are exempt from out …

Highlights•Cardiovascular disease (CVD) is a major source of financial burden and financial
distress, which can cause psychological distress, cost-related care non-adherence or care …

Background Direct out-of-pocket payments (OOP) are among the most important financing
mechanisms in many health systems, especially in developing countries, adversely affecting …

Background: Despite recently expanded access to health insurance, consumers still face
barriers to using their coverage to obtain needed health care. Objective: To examine the …

Background Cancer costs should be discussed by patients and providers, but information is
not readily available. Results from recently published studies (in the last 5 years) on direct …

Background Financial toxicity (FT) is a well-established side-effect of the high costs
associated with cancer care. In recent years, studies have suggested that a significant …

The unprecedented rise in the population of older adults and the number of seniors living
with and managing chronic conditions are straining our institutional health care systems …

Direct and indirect costs of care influence patients' health choices and the ability to
implement those choices. Despite the significant impact of care costs on patients' health and …